A carregar...
Adverse Effects of GLP-1 Receptor Agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of injective anti-diabetic drugs that improve glycemic control and many other atherosclerosis-related parameters in patients with type 2 diabetes (T2D). However, the use of this relatively new class of drugs may be associated with certain...
Na minha lista:
| Publicado no: | Rev Diabet Stud |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SBDR - Society for Biomedical Diabetes Research
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5397288/ https://ncbi.nlm.nih.gov/pubmed/26177483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2014.11.202 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|